HROW
Price
$36.99
Change
+$0.79 (+2.18%)
Updated
Sep 5 closing price
Capitalization
1.37B
72 days until earnings call
TKNO
Price
$4.36
Change
+$0.12 (+2.83%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
233.33M
60 days until earnings call
Interact to see
Advertisement

HROW vs TKNO

Header iconHROW vs TKNO Comparison
Open Charts HROW vs TKNOBanner chart's image
Harrow
Price$36.99
Change+$0.79 (+2.18%)
Volume$355.52K
Capitalization1.37B
Alpha Teknova
Price$4.36
Change+$0.12 (+2.83%)
Volume$335
Capitalization233.33M
HROW vs TKNO Comparison Chart in %
Loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HROW vs. TKNO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a StrongBuy and TKNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (HROW: $36.99 vs. TKNO: $4.36)
Brand notoriety: HROW and TKNO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HROW: 66% vs. TKNO: 24%
Market capitalization -- HROW: $1.37B vs. TKNO: $233.33M
HROW [@Pharmaceuticals: Generic] is valued at $1.37B. TKNO’s [@Pharmaceuticals: Generic] market capitalization is $233.33M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 1 FA rating(s) are green whileTKNO’s FA Score has 0 green FA rating(s).

  • HROW’s FA Score: 1 green, 4 red.
  • TKNO’s FA Score: 0 green, 5 red.
According to our system of comparison, HROW is a better buy in the long-term than TKNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 5 TA indicator(s) are bullish while TKNO’s TA Score has 2 bullish TA indicator(s).

  • HROW’s TA Score: 5 bullish, 4 bearish.
  • TKNO’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, HROW is a better buy in the short-term than TKNO.

Price Growth

HROW (@Pharmaceuticals: Generic) experienced а -5.15% price change this week, while TKNO (@Pharmaceuticals: Generic) price change was +0.93% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

HROW is expected to report earnings on Nov 17, 2025.

TKNO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HROW($1.37B) has a higher market cap than TKNO($233M). HROW YTD gains are higher at: 10.253 vs. TKNO (-49.222). HROW has higher annual earnings (EBITDA): 32.1M vs. TKNO (-14.44M). HROW has more cash in the bank: 53M vs. TKNO (24M). TKNO has less debt than HROW: TKNO (29M) vs HROW (231M). HROW has higher revenues than TKNO: HROW (228M) vs TKNO (38.9M).
HROWTKNOHROW / TKNO
Capitalization1.37B233M588%
EBITDA32.1M-14.44M-222%
Gain YTD10.253-49.222-21%
P/E RatioN/AN/A-
Revenue228M38.9M586%
Total Cash53M24M221%
Total Debt231M29M797%
FUNDAMENTALS RATINGS
HROW: Fundamental Ratings
HROW
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HROWTKNO
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 15 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SBNY0.550.08
+17.02%
Signature Bank (New York, NY)
DNKEY20.490.25
+1.24%
Danske Bank A/S
AKAAF69.00N/A
N/A
Aker AS
SYBJF1.38N/A
N/A
Security Bank Corp.
EXROF0.01N/A
-9.68%
Exro Technologies Inc.

HROW and

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with OGI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+2.18%
OGI - HROW
34%
Loosely correlated
+2.48%
AQST - HROW
34%
Loosely correlated
+7.11%
TKNO - HROW
33%
Poorly correlated
+2.83%
AMRX - HROW
32%
Poorly correlated
+0.73%
EBS - HROW
30%
Poorly correlated
-0.66%
More

TKNO and

Correlation & Price change

A.I.dvisor tells us that TKNO and HROW have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKNO and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKNO
1D Price
Change %
TKNO100%
-0.24%
HROW - TKNO
33%
Poorly correlated
-3.05%
OGI - TKNO
30%
Poorly correlated
-0.62%
EBS - TKNO
30%
Poorly correlated
-2.55%
AMRX - TKNO
29%
Poorly correlated
+0.10%
VTRS - TKNO
28%
Poorly correlated
-2.09%
More